Enovis (ENOV) Divestments (2025)

Enovis' (ENOV) quarterly Divestments came in at $43.3 million in Q4 2025, up 2604.56% on a QoQ basis from $1.6 million in Q2 2025.

Enovis (ENOV) Divestments (2025) Analysis & Trends

Enovis (ENOV) has 1 years of Divestments data on file, last reported at $43.3 million in Q4 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to $43.3 million in Q4 2025; TTM through Dec 2025 was $44.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $43.3 million, changed N/A from the prior year.
  • Divestments for Q4 2025 stood at $43.3 million, up from $1.6 million in the prior quarter.
  • Over the last five years, Divestments for ENOV reached as high as $43.3 million in Q4 2025 and fell as low as $1.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.37 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 43.30 Mn
Apr 4, 2025 1.60 Mn